Výsledky vyhledávání
- 1.FUCHS, O.G Targeting cereblon in hematologic malignancies. Blood reviews. 2023, vol. 57, no. [January], art. no. 100994. ISSN 0268-960X.
- 2.PANDORF, C.E.; ANTHONY, N.I.; FUCHS, O. Non-coding RNAs in human non-infectious diseases. In: SZTUBA-SOLINSKA, J. (ed.) Navigating Non-coding RNA: From Biogenesis to Therapeutic Application [online]. Cambridge: Academic Press, 2023, s. 273-319. ISBN 978-032390406-3. Dostupný z WWW: <https://doi.org/10.1016/C2020-0-03884-3>.
- 3.FUCHS, O.G Proteolysis-targeting chimeras (PROTACs) as novel biotechnology for cancer therapy. In: BARH, D. (ed.) Biotechnology in healthcare, volume 2: applications and initiatives. Cambridge, Massachusetts: Elsevier: Academic Press, 2022, s. 71-88. ISBN 9780323900423. Dostupný z WWW: <https://doi.org/10.1016/B978-0-323-90042-3.15001-7>.
- 4.FUCHS, O.G Iberdomide: cereblon E3 ligase modulator (CELMoD): treatment of systemic lupus erythematosus: treatment of multiple myeloma. Drugs of the future. 2021, vol. 46, no. 2, s. 115-127. ISSN 0377-8282.
- 5.FUCHS, O.G; BOKOROVA, R. Preclinical studies of PROTACs in hematological malignancies. Cardiovascular & hematological disorders drug targets. 2021, vol. 21, no. 1, s. 7-22. ISSN 1871-529X.
- 6.FUCHS, O.G B cell activating factor (BAFF) as therapeutic target in autoimmune and chronic inflammatory diseases. In: BERHADT, L.V. (ed.) Advances in medicine and biology: volume 177 [online]. New York: Nova Science, 2021, s. 83-117. ISBN 978-1-53619-509-5. ISSN 2157-5398. Dostupný z WWW: <https://novapublishers.com/shop/advances-in-medicine-and-biology-volume-177/>.
- 7.FUCHS, O.G Role of b cell activating factor (BAFF) in induction of anti-apoptotic nuclear factor kappa B (NF-KB) expression. In: BERHADT, L.V. (ed.) Advances in medicine and biology: volume 177 [online]. New York: Nova Science, 2021, s. 179-199. ISBN 978-1-53619-509-5. ISSN 2157-5398. Dostupný z WWW: <https://novapublishers.com/shop/advances-in-medicine-and-biology-volume-177/>.
- 8.FUCHS, O.G Treatment of myeloid hematologic malignancies with isocitrate dehydrogenase mutations by inhibitors of this enzyme. In: GIOIA, D.K. (ed.). New research on hematological malignancies [online]. New York: Nova Publishers, 2021, s. 51-88. ISBN 978-1-53619-955-0. Dostupný z WWW: <https://novapublishers.com/shop/new-research-on-hematological-malignancies/>.
- 9.FUCHS, O.G Inhibition of nuclear export as a new therapy in hematologic malignancies. In: GIOIA, D.K. (ed.). New research on hematological malignancies [online]. New York: Nova Publishers, 2021, s. 89-112. ISBN 978-1-53619-955-0. Dostupný z WWW: <https://novapublishers.com/shop/new-research-on-hematological-malignancies/>.
- 10.FUCHS, O.G Poly(ADP-ribose) polymerase inhibitors in the treatment of myelodysplastic syndrome and acute myeloid leukemia. In: GIOIA, D.K. (ed.). New research on hematological malignancies [online]. New York: Nova Publishers, 2021, s. 113-138. ISBN 978-1-53619-955-0. Dostupný z WWW: <https://novapublishers.com/shop/new-research-on-hematological-malignancies/>.